Arrivent BioPharma, Inc. (AVBP)
26.73
-0.27
(-1.00%)
USD |
NASDAQ |
May 22, 16:00
26.74
+0.01
(+0.04%)
After-Hours: 20:00
Arrivent BioPharma Total Assets (Quarterly) : 349.30M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ocugen, Inc. | 56.90M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Agenus, Inc. | 186.46M |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 25.32M |
| Shareholders Equity (Quarterly) | 323.98M |
| Debt to Equity Ratio | 0.0013 |
| Current Ratio | 13.95 |
| Net Debt Paydown Yield | -0.01% |